Top Wall Street analysts have made some notable changes to their outlook on certain stocks. For a comprehensive overview of all the analyst rating changes, including upgrades and downgrades, please refer to our analyst ratings page.
Morgan Stanley analyst Ronald Kamdem has raised the price target for Regency Centers Corporation (NASDAQ:REG) from $62 to $75. Additionally, Kamdem upgraded the stock from Equal-Weight to Overweight. Despite this positive news, Regency Centers shares experienced a slight decline of 1.3%, closing at $65.54 on Wednesday. To get a broader perspective on how other analysts view this stock, be sure to check it out.
Wedbush analyst Scott Devitt has increased the price target for Amazon.com, Inc. (NASDAQ:AMZN) from $180 to $210. Devitt has maintained an Outperform rating for the stock. However, Amazon shares saw a 1.1% drop, closing at $152.12 on Wednesday. To gain insights into how other analysts perceive this stock, take a look at their views.
Wells Fargo analyst Derek Archila has lowered the price target for argenx SE (NASDAQ:ARGX) from $585 to $470. Nevertheless, Archila has maintained an Overweight rating for the stock. Unfortunately, argenx shares experienced a significant decline of 25.1%, closing at $338.91 on Wednesday. To understand the perspectives of other analysts on this stock, make sure to explore their views.
Deutsche Bank analyst Sidney Ho has raised the price target for Micron Technology, Inc. (NASDAQ:MU) from $85 to $90. Ho has maintained a Buy rating for the stock. However, Micron shares saw a 4.2% decrease, closing at $78.69 on Wednesday. To gain further insights into how other analysts view this stock, be sure to check it out.
HC Wainwright & Co. analyst Douglas Tsao has increased the price target for Immunovant, Inc. (NASDAQ:IMVT) from $47 to $51. Tsao has maintained a Buy rating for the stock. Unfortunately, Immunovant shares experienced a decline of 12.8%, closing at $36.18 on Wednesday. To understand the perspectives of other analysts on this stock, make sure to explore their views.
Needham analyst Alex Henderson has raised the price target for CrowdStrike Holdings, Inc. (NASDAQ:CRWD) from $250 to $325. Henderson has maintained a Buy rating for the stock. However, CrowdStrike shares saw a 1.7% decrease, closing at $253.95 on Wednesday. To gain further insights into how other analysts view this stock, be sure to check it out.
Morgan Stanley analyst Keith Weiss has increased the price target for Salesforce, Inc. (NYSE:CRM) from $290 to $350. Additionally, Weiss upgraded the stock from Equal-Weight to Overweight. Despite this positive news, Salesforce shares experienced a 1.6% decline, closing at $260.25 on Wednesday. To get a broader perspective on how other analysts view this stock, be sure to check it out.
Pivotal Research analyst Jeffrey Wlodarczak has raised the price target for Spotify Technology S.A. (NYSE:SPOT) from $170 to $265. Furthermore, Wlodarczak upgraded the stock from Hold to Buy. Unfortunately, Spotify shares saw a 1.1% decrease, closing at $188.71 on Wednesday. To gain further insights into how other analysts view this stock, be sure to check it out.
Baird analyst Jeff Johnson has increased the price target for Insulet Corporation (NASDAQ:PODD) from $180 to $238. Additionally, Johnson upgraded the stock from Neutral to Outperform. However, Insulet shares experienced a 3.1% decline, closing at $207.97 on Wednesday. To get a broader perspective on how other analysts view this stock, be sure to check it out.
JP Morgan analyst Allen Gong has raised the price target for Glaukos Corporation (NYSE:GKOS) from $66 to $91. Gong has also upgraded the stock from Neutral to Overweight. Despite this positive news, Glaukos shares saw a 2% decrease, closing at $79.60 on Wednesday. To gain further insights into how other analysts view this stock, be sure to check it out.
Lastly, don’t forget to check out our article on Micron, Carnival, and three other stocks to watch heading into Thursday.